Quantcast
Channel: PR Newswire:
People Here Also Viewed:
Viewing all articles
Browse latest Browse all 51512

Bayer Initiates Phase III Trial of an Investigational Recombinant Factor VIII Compound in Children with Hemophilia A

0
0
WAYNE, N.J., July 8, 2013 /PRNewswire/ -- Bayer HealthCare today announced the company has started to enroll patients in an international Phase II/III trial to evaluate its investigational compound BAY94-9027 for the treatment of hemophilia A in children.  The PROTECT VIII...

Viewing all articles
Browse latest Browse all 51512

Latest Images

Trending Articles





Latest Images